Skip to main content
Q

QuantaMatrix Incorporated — Investor Relations & Filings

Ticker · 317690 ISIN · KR7317690006 KO Manufacturing
Open in API
Filings indexed 155 across all filing types
Latest filing 2020-12-03 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 317690

About QuantaMatrix Incorporated

https://www.quantamatrix.com/

QuantaMatrix Incorporated is an in-vitro diagnostics (IVD) company specializing in the development and manufacturing of medical devices using microbial diagnostics technology. The company focuses on providing rapid diagnostic solutions for critical conditions, with a primary emphasis on sepsis. Its flagship product, dRAST™ (direct & Rapid Antimicrobial Susceptibility Test), significantly reduces the time for determining effective antibiotics for sepsis patients, providing results in as few as four hours from a positive blood culture, compared to several days for conventional methods. This technology, which utilizes microfluidic channels and time-lapse microscopic imaging, enables faster, targeted antimicrobial therapy. In addition to sepsis, QuantaMatrix develops diagnostic solutions for other areas, including tuberculosis (QDST™), Alzheimer's disease (QPLEX™), and cardiovascular diseases.

Recent filings

Filing Released Lang Actions
증권발행실적보고서
Share Issue/Capital Change Classification · 1% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. It details the final results of a public offering, including subscription amounts, allocation status, and the use of proceeds. This type of filing is a standard regulatory disclosure regarding capital changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2020-12-03 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Securities Registration Statement' (증권신고서) amendment filed with the Financial Services Commission in South Korea. It details corrections to the demand forecasting results and share issuance terms for QuantaMatrix. Since this is a formal regulatory filing regarding the issuance of new shares and capital changes, it falls under the 'Share Issue/Capital Change' category.
2020-11-30 Korean
[기재정정]투자설명서
M&A Activity Classification · 1% confidence The document is a 'Investment Prospectus' (투자설명서) for QuantaMatrix (주식회사 퀀타매트릭스). It contains detailed information regarding the public offering, including demand forecasting results, share pricing, risk factors, and business outlook. This document is a formal regulatory filing required for an IPO or public offering of securities. In the context of the provided categories, 'Proxy Solicitation & Information Statement' (PSI) is the closest fit for a document that provides detailed information to potential investors/shareholders regarding a specific corporate action (offering), although it is technically a prospectus. Given the specific options, PSI is the standard classification for such disclosure documents.
2020-11-30 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 1% confidence The document is a '증권신고서(지분증권)' (Securities Registration Statement) filed with the Financial Services Commission in South Korea. It details the finalization of the public offering price (공모가액 확정) for QuantaMatrix Co., Ltd. and includes a '정정신고서' (Amendment to Registration Statement) to update the offering terms. This type of regulatory filing for capital raising and public offerings is classified as a 'Regulatory Filing' (RNS) within the provided schema, as it is a formal submission to a regulatory body regarding securities issuance.
2020-11-27 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 1% confidence The document is a 'Correction Report' (정정신고서) for a 'Prospectus' (투자설명서) related to a public offering of shares by QuantaMatrix. It details changes to the offering price, total offering amount, and underwriting fees following the completion of demand forecasting. This type of filing is a regulatory document related to capital raising and share issuance, which falls under the 'Share Issue/Capital Change' category in the provided schema.
2020-11-27 Korean
투자설명서
Capital/Financing Update Classification · 1% confidence The document is a '투자설명서' (Investment Prospectus) for QuantaMatrix, filed in November 2020. It contains detailed information regarding a public offering, including offering price, subscription period, risk factors, and financial projections. In the context of Korean financial filings (DART), this is a formal securities registration statement/prospectus used for IPOs or capital raising, which falls under the 'Proxy Solicitation & Information Statement' (PSI) category as it provides essential information to potential investors for their decision-making process.
2020-11-24 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.